192 related articles for article (PubMed ID: 7925269)
1. Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA.
Barlow C; Meister B; Lardelli M; Lendahl U; Vennström B
EMBO J; 1994 Sep; 13(18):4241-50. PubMed ID: 7925269
[TBL] [Abstract][Full Text] [Related]
2. The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma.
Ventura-Holman T; Mamoon A; Subauste MC; Subauste JS
Mol Biol Rep; 2011 Feb; 38(2):1137-44. PubMed ID: 20571909
[TBL] [Abstract][Full Text] [Related]
3. The v-erbA oncogene selectively inhibits iodide uptake in rat thyroid cells.
Trapasso F; Martelli ML; Battaglia C; Angotti E; Mele E; Stella A; Samarut J; Avvedimento VE; Fusco A
Oncogene; 1996 May; 12(9):1879-88. PubMed ID: 8649848
[TBL] [Abstract][Full Text] [Related]
4. v-erbA acts on retinoic acid receptors in immature avian erythroid cells.
Sande S; Sharif M; Chen H; Privalsky M
J Virol; 1993 Feb; 67(2):1067-74. PubMed ID: 8093487
[TBL] [Abstract][Full Text] [Related]
5. Altered expression after expansion of a v-erbA transgene in transgenic mice.
Barlow C; Meister B; Lendahl U; Vennström B
Transgenic Res; 1995 Nov; 4(6):378-87. PubMed ID: 7581518
[TBL] [Abstract][Full Text] [Related]
6. v-erbA oncogene initiates ultrastructural changes characteristic of early and intermediate events of meiotic maturation in Xenopus oocytes.
Nagl SB; Bunn CF; Allison LA
J Cell Biochem; 1997 Nov; 67(2):184-200. PubMed ID: 9328824
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the v-erbA protein is required for its function as an oncogene.
Glineur C; Zenke M; Beug H; Ghysdael J
Genes Dev; 1990 Oct; 4(10):1663-76. PubMed ID: 1979040
[TBL] [Abstract][Full Text] [Related]
8. Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells.
Iglesias T; Llanos S; López-Barahona M; Seliger B; Rodríguez-Peña A; Bernal J; Muñoz A
Oncogene; 1995 Mar; 10(6):1103-10. PubMed ID: 7700635
[TBL] [Abstract][Full Text] [Related]
9. v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action.
Sharif M; Privalsky ML
Cell; 1991 Sep; 66(5):885-93. PubMed ID: 1679679
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-erbA in human hepatocellular carcinomas.
Arbuthnot P; Kew M; Parker I; Fitschen W
Anticancer Res; 1989; 9(4):885-7. PubMed ID: 2554788
[TBL] [Abstract][Full Text] [Related]
11. V-erbA requires auxiliary proteins for dominant negative activity.
Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
Selmi S; Samuels HH
J Biol Chem; 1991 Jun; 266(18):11589-93. PubMed ID: 1675637
[TBL] [Abstract][Full Text] [Related]
13. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.
Usala SJ; Tennyson GE; Bale AE; Lash RW; Gesundheit N; Wondisford FE; Accili D; Hauser P; Weintraub BD
J Clin Invest; 1990 Jan; 85(1):93-100. PubMed ID: 2153155
[TBL] [Abstract][Full Text] [Related]
14. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
[TBL] [Abstract][Full Text] [Related]
15. Competitive polymerase chain reaction quantitation of c-erbA beta 1, c-erbA alpha 1, and c-erbA alpha 2 messenger ribonucleic acid levels in normal, heterozygous, and homozygous fibroblasts of kindred S with thyroid hormone resistance.
Klann RC; Torres B; Menke JB; Holbrook CT; Bercu BB; Usala SJ
J Clin Endocrinol Metab; 1993 Oct; 77(4):969-75. PubMed ID: 8408473
[TBL] [Abstract][Full Text] [Related]
16. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
[TBL] [Abstract][Full Text] [Related]
17. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
Rascle A; Ferrand N; Gandrillon O; Samarut J
Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
[TBL] [Abstract][Full Text] [Related]
18. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
Damm K; Evans RM
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
[TBL] [Abstract][Full Text] [Related]
19. v-erbA oncogene induces invasiveness and anchorage-independent growth in cultured glial cells by mechanisms involving platelet-derived growth factor.
Llanos S; Iglesias T; Riese HH; Garrido T; Caelles C; Muñoz A
Cell Growth Differ; 1996 Mar; 7(3):373-82. PubMed ID: 8838867
[TBL] [Abstract][Full Text] [Related]
20. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
